000			01702nam a2200373Ia 4500
001			ebr10606369
003			CaPaEBR
006			m u
007			cr cn|||||||||
008			111220s2012 dcua sb 000 0 eng d
020			_a9780309253154
020			_a0309253152
040			_aCaPaEBR _cCaPaEBR
035			_a(OCoLC)813396119
049			_aAlfaisal Main Library
050	1	4	_aR853.C55 _bE585 2012eb
245	0	0	_aEnvisioning a transformed clinical trials enterprise in the United States _h[electronic resource] : _bestablishing an agenda for 2020: workshop summary / _cNeil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.
260			_aWashington : _bNational Academies Press, _c2012.
300			_axvi, 232 p. : _bill.
504			_aIncludes bibliographical references.
533			_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2011. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries.
650		0	_aClinical trials _zUnited States.
650		0	_aClinical medicine _xResearch _zUnited States.
655		7	_aElectronic books. _2local
700	1		_aWeisfeld, Neil E.
700	1		_aEnglish, Rebecca A.
700	1		_aClaiborne, Anne B.
710	2		_aebrary, Inc.
710	2		_aInstitute of Medicine (U.S.). _bForum on Drug Discovery, Development, and Translation.
710	2		_aInstitute of Medicine (U.S.). _bBoard on Health Sciences Policy.
710	2		_aNational Academies Press (U.S.)
856	4	0	_uhttp://ezproxy.alfaisal.edu/login?url=http://site.ebrary.com/lib/alfaisal/Doc?id=10606369
942			_2lcc _cEBOOKS
999			_c207681 _d207681